A new study published in The New England Journal of Medicine showed that Fremanezumab reduced migraine and headache days more...

A new study published in the Journal of the American Medical Association showed that for juvenile dermatomyositis (JDM), a combination...

The MAJESTY global phase 3 study evaluating obinutuzumab (Gazyva) in primary membranous nephropathy (PMN) demonstrated positive efficacy and safety outcomes....

New Delhi: The Supreme Court sought responses from the Union government and the Drug Controller General of India regarding an...

New Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated...

Mumbai: Indian drugmaker Dr Reddy’s Laboratories is likely to launch its generic semaglutide injection in the country in March under...

Lucknow: The Allahabad High Court has refused to grant regular bail to two individuals accused in a case involving the...

New Delhi: Aurobindo Pharma Limited announced that its wholly owned subsidiary, Eugia Pharma Specialities Limited, has received final approval from...

Latent valvular damage in children often escapes routine detection, as the prevalence of subclinical Rheumatic Heart Disease (RHD) in Meghalaya...